3-O-METHYLDOPA AND THE RESPONSE TO LEVODOPA IN PARKINSONS-DISEASE

被引:120
作者
NUTT, JG
WOODWARD, WR
GANCHER, ST
MERRICK, D
机构
关键词
D O I
10.1002/ana.410210610
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:584 / 588
页数:5
相关论文
共 50 条
[31]   MOTOR RESPONSE TO APOMORPHINE AND LEVODOPA IN ASYMMETRIC PARKINSONS-DISEASE - REPLY [J].
RODRIGUEZ, M ;
LERA, G ;
OBESO, JA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (11) :1444-1444
[32]   DEPRENYL IN THE MANAGEMENT OF RESPONSE FLUCTUATIONS IN PATIENTS WITH PARKINSONS-DISEASE ON LEVODOPA [J].
SCHACHTER, M ;
MARSDEN, CD ;
PARKES, JD ;
JENNER, P ;
TESTA, B .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1980, 43 (11) :1016-1021
[33]   THE IMPACT OF TREATMENT WITH LEVODOPA ON PARKINSONS-DISEASE [J].
SHAW, KM ;
LEES, AJ ;
STERN, GM .
QUARTERLY JOURNAL OF MEDICINE, 1980, 49 (195) :283-293
[34]   AMANTADINE AND LEVODOPA IN TREATMENT OF PARKINSONS-DISEASE [J].
TOURTELL.WW ;
POTVIN, AR ;
HENDERSO.WG ;
WALKER, JE .
NEUROLOGY, 1974, 24 (04) :400-400
[35]   METABOLIC PATTERNS AND CLINICAL RESPONSE TO LEVODOPA THERAPY IN PARKINSONS-DISEASE [J].
MESSIHA, FS ;
KNOPP, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (04) :565-571
[36]   SOCIOPSYCHOLOGICAL FACTORS INFLUENCING RESPONSE TO LEVODOPA THERAPY FOR PARKINSONS-DISEASE [J].
SINGER, E .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1976, 57 (07) :328-334
[37]   LEVODOPA PERIPHERAL PHARMACOKINETICS AND DURATION OF MOTOR RESPONSE IN PARKINSONS-DISEASE [J].
KEMPSTER, PA ;
FRANKEL, JP ;
BOVINGDON, M ;
WEBSTER, R ;
LEES, AJ ;
STERN, GM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (06) :718-723
[38]   BROMOCRIPTINE COMBINED WITH LEVODOPA IN PARKINSONS-DISEASE [J].
GAUTHIER, G ;
DASILVA, AM .
EUROPEAN NEUROLOGY, 1982, 21 (04) :217-226
[39]   DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE [J].
BLIN, J ;
BONNET, AM ;
AGID, Y .
NEUROLOGY, 1988, 38 (09) :1410-1416
[40]   PIGMENTATION IN PARKINSONS-DISEASE TREATED WITH LEVODOPA [J].
GRAINGER, KM .
LANCET, 1973, 1 (7794) :97-98